Eptinezumab for Prevention of Chronic Migraine (CM): Results of 2 Quarterly Intravenous Infusions in the Phase 3 PROMISE-2 (PRevention of Migraine via Intravenous Eptinezumab Safety and efficacy-2) Trial

R. B. Lipton, P. J. Goadsby, J. Azimova,M. Ashina, E. L. H. Spierings, P. K. Winner,B. Schaeffler,D. Biondi,S. Bhattacharya,J. Smith,R. Cady

HEADACHE(2018)

引用 1|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要